To access this clip without audiomarks, please purchase it, or upgrade your account.
Date
Summary
Dr. Fauci: We Don’t Know How Durable the Effect of Pfizer Vaccine Will Be
Source
CNN
Name: CNN
URL: http://www.cnn.com/
Show
State of the Union With Jake Tapper and Dana Bash (CNN)
Name: State of the Union With Jake Tapper and Dana Bash (CNN)
URL: https://www.cnn.com/shows/state-of-the-union
Persons
Dana Bash
, Anthony Fauci
Name: Dana Bash
Employment: CNN
Position: Senior congressional correspondent
Name: Anthony Fauci
Employment: National Institute of Allergy and Infectious Diseases (NIAID)
Position: Director
Event
–
Event location
–
Link
–
Original recording
Uploaded
02/21/2021 10:08 am
Owner
Ante (staff)
Type
Video
Format
MP4 (720x400)
Use clipper to adjust file type
Duration
0:02:41
Views
32
Purchases
4
Transcript
RUSH TRANSCRIPT Happen with ░░░░░░░░ U K Variant Let ░░░░░░░░ talk a little bit ░░░░░░░░ about vac veins New ░░░░░░░░ suggests one shot of ░░░░░░░░ Pfizer vaccine can provide ░░░░░░░░ the U K Is ░░░░░░░░ second doses Can you ░░░░░░░░ to Americans why the ░░░░░░░░ S Is adjusting it ░░░░░░░░ strategy when millions of ░░░░░░░░ that want a vaccine ░░░░░░░░ to get one Dana ░░░░░░░░ s a good question ░░░░░░░░ answer is that we ░░░░░░░░ to do first of ░░░░░░░░ there are two scenarios ░░░░░░░░ one you re talking ░░░░░░░░ Pfizer giving one dose ░░░░░░░░ having a good degree ░░░░░░░░ protection versus what they ░░░░░░░░ doing in the U ░░░░░░░░ So let me very ░░░░░░░░ explain both The Pfizer ░░░░░░░░ where they gave a ░░░░░░░░ and after a period ░░░░░░░░ time at 15 to ░░░░░░░░ days they had good ░░░░░░░░ What we don t ░░░░░░░░ and this is risky ░░░░░░░░ about it we don ░░░░░░░░ know how durable that ░░░░░░░░ is going to be ░░░░░░░░ know for sure that ░░░░░░░░ you give a prime ░░░░░░░░ the Pfizer followed by ░░░░░░░░ boost 21 days later ░░░░░░░░ you get a 94 ░░░░░░░░ 95 E efficacy and ░░░░░░░░ antibodies after one dose ░░░░░░░░ two doses is tenfold ░░░░░░░░ and that is really ░░░░░░░░ because when you have ░░░░░░░░ high a degree comparable ░░░░░░░░ the single dose alone ░░░░░░░░ s the cushion that ░░░░░░░░ would like to have ░░░░░░░░ you get a variant ░░░░░░░░ isn t as well ░░░░░░░░ against by the antibodies ░░░░░░░░ by the vaccine but ░░░░░░░░ have enough level to ░░░░░░░░ able to prevent at ░░░░░░░░ severe disease So the ░░░░░░░░ points directly towards continuing ░░░░░░░░ what we know about ░░░░░░░░ the clinical trial We ░░░░░░░░ keep an open mind ░░░░░░░░ continue to look at ░░░░░░░░ and make decisions based ░░░░░░░░ the evidence in the ░░░░░░░░ Very quickly the situation ░░░░░░░░ the U K A ░░░░░░░░ different because they re ░░░░░░░░ about an entirely different ░░░░░░░░ platform They re talking ░░░░░░░░ a vaccine that was ░░░░░░░░ using a chimp as ░░░░░░░░ to the mRNA They ░░░░░░░░ not comparable when you ░░░░░░░░ about the duration that ░░░░░░░░ ll wait before you ░░░░░░░░ the second dose when ░░░░░░░░ re talking about Pfizer ░░░░░░░░ modern which is what ░░░░░░░░ re using here in ░░░░░░░░ United States.
>> Really important explanation
>> Really important explanation
To view this clip's transcript, log into your Grabien account.
